Thomas J. Lynch Jr was appointed executive vice president and chief scientific officer of Bristol- Myers Squibb. Previous to this appointment, Dr. Lynch served as chairman and chief executive officer of Massachusetts General Physicians Organization and as a member of the MGH Board. Prior to that Dr. Lynch was the director of Yale Cancer Center and was the Richard and Jonathan Sackler Professor of Internal Medicine at the Yale School of Medicine.
Sign up for news updates
Thomas J. Lynch Jr, MD
|
|
Estimated Read Time:
1–2 minutes
Share this Article:
Recent Posts
-
September 11, 2026
-
September 11, 2026
-
Panelists to Offer Practical Advice for Engaging Policymakers to Improve Early Lung Cancer Detection
September 11, 2026 -
September 11, 2026
View ILCN Archives
Provider Resources
Popular Articles
-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care